THE THERAPEUTIC EFFECTS OF SINGING IN NEUROLOGICAL DISORDERS

被引:91
|
作者
Wan, Catherine Y.
Rueber, Theodor
Hohmann, Anja
Schlaug, Gottfried [1 ]
机构
[1] Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA
来源
MUSIC PERCEPTION | 2010年 / 27卷 / 04期
关键词
singing; treatment; stuttering; Parkinson's disease; aphasia; autism; MELODIC INTONATION THERAPY; PARKINSONS-DISEASE; SPEECH; FREQUENCY; APHASIA; INTELLIGIBILITY; REDUCTION; MUSICIANS; ACCURACY; SPEAKING;
D O I
10.1525/MP.2010.27.4.287
中图分类号
J6 [音乐];
学科分类号
摘要
MUSIC MAKING ( PLAYING AN INSTRUMENT OR SINGING) is a multimodal activity that involves the integration of auditory and sensorimotor processes. The ability to sing in humans is evident from infancy, and does not depend on formal vocal training but can be enhanced by training. Given the behavioral similarities between singing and speaking, as well as the shared and distinct neural correlates of both, researchers have begun to examine whether singing can be used to treat some of the speech-motor abnormalities associated with various neurological conditions. This paper reviews recent evidence on the therapeutic effects of singing, and how it can potentially ameliorate some of the speech deficits associated with conditions such as stuttering, Parkinson's disease, acquired brain lesions, and autism. By reviewing the status quo, it is hoped that future research can help to disentangle the relative contribution of factors to why singing works. This may ultimately lead to the development of specialized or "gold-standard" treatments for these disorders, and to an improvement in the quality of life for patients.
引用
收藏
页码:287 / 295
页数:9
相关论文
共 50 条
  • [1] Therapeutic Effects of Progesterone in Animal Models of Neurological Disorders
    De Nicola, Alejandro F.
    Coronel, Florencia
    Garay, Laura I.
    Gargiulo-Monachelli, Gisella
    Gonzalez Deniselle, Maria Claudia
    Gonzalez, Susana L.
    Labombarda, Florencia
    Meyer, Maria
    Guennoun, Rachida
    Schumacher, Michael
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2013, 12 (08) : 1205 - 1218
  • [2] Narrative Review on Therapeutic Effects of Dietary Approach in Neurological Disorders
    Stroe, Alina Z.
    Axelerad, Silviu D.
    Gogu, Anca E.
    Chita, Dana S.
    Frecus, Corina E.
    Mihai, Cristina M.
    JOURNAL OF COMPLEMENTARY MEDICINE RESEARCH, 2022, 13 (03): : 33 - 41
  • [3] Therapeutic Effects of Catechins in Less Common Neurological and Neurodegenerative Disorders
    Sebastiani, Giorgia
    Almeida-Toledano, Laura
    Serra-Delgado, Mariona
    Navarro-Tapia, Elisabet
    Sailer, Sebastian
    Valverde, Olga
    Garcia-Algar, Oscar
    Andreu-Fernandez, Vicente
    NUTRIENTS, 2021, 13 (07)
  • [4] Therapeutic apheresis in neurological disorders
    Weinstein, R
    JOURNAL OF CLINICAL APHERESIS, 2000, 15 (1-2) : 74 - 128
  • [5] THERAPEUTIC PLASMAPHERESIS IN NEUROLOGICAL DISORDERS
    TOYKA, KV
    AKTUELLE NEUROLOGIE, 1984, 11 (04) : 114 - 117
  • [6] The therapeutic effects of erythropoietin and carbamylated erythropoietin derivatives in neurological and other disorders
    Maghsoudi, Amirhossein
    Zaringhalam, Jalal
    Moosavi, Maryam
    Eidi, Akram
    PHYSIOLOGY AND PHARMACOLOGY, 2023, 27 (04): : 345 - 356
  • [7] The Therapeutic Potential of Melatonin in Neurological Disorders
    Bhavsar, Bhavini
    Farooq, Muhammad U.
    Bhatt, Archit
    RECENT PATENTS ON ENDOCRINE METABOLIC & IMMUNE DRUG DISCOVERY, 2009, 3 (01) : 60 - 64
  • [8] Therapeutic Strategy of Erythropoietin in Neurological Disorders
    Liu, Xiang-Bao
    Wang, Jiang-An
    Yu, Shan Ping
    Keogh, Christine L.
    Wei, Ling
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2008, 7 (03) : 227 - 234
  • [9] The therapeutic potential of statins in neurological disorders
    Rajanikant, G. K.
    Zemke, D.
    Kassab, M.
    Majid, A.
    CURRENT MEDICINAL CHEMISTRY, 2007, 14 (01) : 103 - 112
  • [10] Therapeutic potential of fluoxetine in neurological disorders
    Mostert, Jop P.
    Koch, Marcus W.
    Heerings, Marco
    Heersema, Dorothea J.
    De Keyser, Jacques
    CNS NEUROSCIENCE & THERAPEUTICS, 2008, 14 (02) : 153 - 164